Sign in
4

Changes in Ownership

PharmaCyte Biotech, Inc. Filed Acc 0001683168-23-008431

Options or other derivatives

  • Interim CEO, Interim President acquired 170,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Silverman Joshua · Interim CEO, Interim President

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-11-20 Grant or award : show line 1 in the form Stock Option (Right to Buy) +170,000 170,000 D
Loading xslF345X05/ownership.xml…